fosfomycin mg pharma 3000 mg granulat zur herstellung einer lösung zum einnehmen
monurol powder for solution
paladin labs inc. - fosfomycin (fosfomycin tromethamine) - powder for solution - 3g - fosfomycin (fosfomycin tromethamine) 3g - urinary anti-infectives
ivozfo powder for solution
verity pharmaceuticals inc. - fosfomycin (fosfomycin sodium) - powder for solution - 2g - fosfomycin (fosfomycin sodium) 2g - urinary anti-infectives
ivozfo powder for solution
verity pharmaceuticals inc. - fosfomycin (fosfomycin sodium) - powder for solution - 4g - fosfomycin (fosfomycin sodium) 4g - urinary anti-infectives
ivozfo powder for solution
verity pharmaceuticals inc. - fosfomycin (fosfomycin sodium) - powder for solution - 8g - fosfomycin (fosfomycin sodium) 8g - urinary anti-infectives
pbac fosvet 250mgg water soluble powder
life biopharma sdn. bhd. - fosfomycin calcium -
fosvet-t water soluble powder
life biopharma sdn. bhd. - fosfomycin calcium; tylosin tartrate -
fosfomycin adco powder
adcock ingram limited - powder - not indicated - none
fomicyt 2 g.
tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 2 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.
fomicyt 4 g.
tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 4 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.